Loading
Latest filing published 20 Mar 2025 for Aptose Biosciences Inc..
No signal scores available.
Hanmi Pharmaceutical Co., Ltd. discloses dealings in Aptose Biosciences Inc. to SEC (Form 4). The record holds 2 filings, for trades running from 18 February 2025 to 19 March 2025.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 20 March 2025, the filings show a transaction in Aptose Biosciences Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations